NanoVibronix, Inc. (NASDAQ:NAOV) Short Interest Down 94.2% in February

NanoVibronix, Inc. (NASDAQ:NAOV) was the recipient of a significant drop in short interest during the month of February. As of February 15th, there was short interest totalling 95,700 shares, a drop of 94.2% from the January 31st total of 1,660,000 shares. Based on an average trading volume of 3,450,000 shares, the days-to-cover ratio is currently 0.0 days. Approximately 1.1% of the company’s shares are short sold.

NanoVibronix Stock Up 7.6 %

Shares of NanoVibronix stock traded up $0.02 during trading on Thursday, reaching $0.35. 145,369 shares of the company were exchanged, compared to its average volume of 5,514,046. The business has a 50-day moving average price of $0.49 and a 200-day moving average price of $0.58. The firm has a market capitalization of $3.05 million, a price-to-earnings ratio of -0.28 and a beta of 1.63. NanoVibronix has a twelve month low of $0.31 and a twelve month high of $1.27.

NanoVibronix Company Profile

NanoVibronix, Inc, through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its product portfolio includes UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use.